Skip to main content

Table 5 Differentially expressed genes

From: Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

Entrez ID

Probe name

Gene name

Encoded protein

Log2-fold difference

Adjusted p-value (false discovery rate)

50487

A_23_P17814

PLA2G3

Phospholipase A2, group III

-3.1

1.1E-12

81579

A_23_P30020

PLA2G12A

Phospholipase A2, group XII A

-1.6

2.5E-9

56994

A_23_P105571

CHPT1

Choline phosphotransferase 1

-1.4

1.6E-7

23446

A_23_P216630

SLC44A1

Solute carrier family 44, member 1 (CTL1)

-1.1

7.9E-7

5338

A_23_P4308

PLD2

Phospholipase D2

-1.1

1.2E-6

8399

A_23_P88767

PLA2G10

Phospholipase A2, group X

-1.1

3.1E-6

1119

A_23_P314120

CHKB

Choline kinase beta

-0.8

2.0E-6

11313

A_24_P276490

LYPLA2

Lysophospholipase II

-0.4

0.005

5130

A_23_P252681

PCYT1A

Phosphate cytidylyltransferase 1, choline, alpha

-0.4

0.035

24657

A_23_P84666

GDPD1

Glycerophosphodiester phosphodiesterase domain containing I

-0.4

0.005

1119

A_23_P124742

CHKA

Choline kinase, alpha

-0.3

0.047

  1. Genes directly involved in choline metabolism with significantly lower expression in basal-like (MAS98.12) than luminal-like (MAS98.06) tumors